Established in 2008, Harvard Catalyst | The Harvard Clinical and Translational Science Center is dedicated to improving human health by enabling collaboration and providing tools, training, and technologies to clinical and translational investigators.
As a shared enterprise of the University, Harvard Catalyst is funded by the National Institutes of Health (NIH) Clinical and Translational Science Awards (CTSA) Program (grant UL1 TR001102), Harvard University, and its affiliated healthcare centers.
Resources are freely available to all Harvard faculty, regardless of institutional affiliation or academic degree.
Here are just a few of the resources they offer:
Harvard Catalyst Profiles is a nationally recognized search tool to find Harvard faculty by key terms and specializations.
Conduct a clinical study:
In-patient and out-patient facilities at BCH, BIDMC, BWH, and MGH; research nursing; coordination; nutrition; laboratory assays and other clinical research resources.
Enter a training program:
Advanced mentored training and research (KL2); a two-year master’s degree program; and Grant Review and Support Program (GRASP).
Expedite a multi-site study:
Use SMART IRB to move your study forward.
Consultations are available on biostatistics and research design, population health research, regulatory, and bioinformatics.
Receive pilot funding:
Opportunities have included childhood obesity, health disparities, advanced imaging, and advanced microscopy. Check pilot funding page for new opportunities.
Use Harvard Catalyst informatics tools:
Access de-identified patient data with SHRINE, and share research resources with other labs using eagle-i (eagle-i.net).
Take a course:
A complete portfolio of clinical and translational research education is offered throughout the year.
About the Mass General Research Institute
Massachusetts General Hospital is home to the largest hospital-based research program in the United States. Our researchers work side-by-side with physicians to develop innovative new ways to diagnose, treat and prevent disease.
Support our research